FDA Seems Unlikely To Move Hydrocodone To Stricter Class
A key U.S. Food and Drug Administration official appeared to be leaning against recommending that hydrocodone-based painkillers be reclassified to a more restrictive drug schedule, according to new documents — a...To view the full article, register now.
Already a subscriber? Click here to view full article